|
KR20160088914A
|
|
New treatment of chronic ulcers
|
|
WO2015075406A1
|
|
New treatment of chronic ulcers
|
|
KR20100049039A
|
|
New medical products
|
|
WO2008084253A1
|
|
Use of a galactolipid for wound and ulcer healing
|
|
AU2007262776A1
|
|
Use cathelicidin antimicrobial protein (hCAP18 ) as anticancer agent
|
|
GB0608797D0
|
|
Novel agents and the use thereof
|
|
GB0608806D0
|
|
Combination therapy product and uses thereof
|
|
WO2006067402A2
|
|
Agents inibiting the cathelin-like protein cap18/ll-37
|
|
WO2006011849A1
|
|
New use
|
|
US2008038374A1
|
|
New Use
|
|
CA2556690A1
|
|
New complexes
|
|
CA2513598A1
|
|
Use of the cathelicidin ll-37 and derivatives thereof for wound healing
|
